Skip to main content
Advertisement
Advertisement
GMED
GMED logo
GLOBUS MEDICAL INC
75.18
USD
Sponsored
+4.13
+5.82%
Nov 09, 13:32 UTC -5
Open

GLOBUS MEDICAL INC (GMED) Earnings

GMED Earnings Reports

Positive Surprise Ratio

GMED beat 30 of 44 last estimates.

68%

Next Report

Date of Next Report
Feb 22, 2027
Estimate for Q4 26 (Revenue/ EPS)
$798.14M
/
$1.31
Implied change from Q3 26 (Revenue/ EPS)
+4.51%
/
+6.50%
Implied change from Q4 25 (Revenue/ EPS)
-3.42%
/
+2.34%

GLOBUS MEDICAL INC earnings per share and revenue

On Nov 05, 2026, GMED reported earnings of 1.23 USD per share (EPS) for Q3 26, beating the estimate of 1.22 USD, resulting in a 0.75% surprise. Revenue reached 763.72 million, compared to an expected 808.26 million, with a -5.51% difference. The market reacted with a -12.76% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 1.31 USD, with revenue projected to reach 798.14 million USD, implying an increase of 6.50% EPS, and increase of 4.51% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
logo
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
logo
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
logo
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
logo
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
logo
Delcath Systems Inc
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.08
Actual
$0.17
Surprise
+300.00%
logo
Orthofix Medical Inc. Common Stock (DE)
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.27
Actual
$0.18
Surprise
+166.59%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
logo
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.31
Actual
-$0.24
Surprise
+23.27%
FAQ
For Q3 2026, GLOBUS MEDICAL INC reported EPS of $1.23, beating estimates by 0.75%, and revenue of $763.72M, -5.51% below expectations.
The stock price moved down -12.76%, changed from $81.44 before the earnings release to $71.05 the day after.
The next earning report is scheduled for Feb 22, 2027.
Based on -- analysts, GLOBUS MEDICAL INC is expected to report EPS of $1.31 and revenue of $798.14M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement